Metformin and dietary advice to improve insulin sensitivity and promote Gestational Restriction of Weight in pregnant women who are obese: the GRoW randomised trial

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Obesity is a significant health issue during pregnancy and childbirth associated with well documented risks. Women who are obese commence pregnancy in a state of increased insulin resistance, the altered metabolic and inflammatory environment providing an excess of nutrients, and a stimulus to fetal growth. The aims of the GRoW randomised trial are to evaluate the effects of metformin and dietary advice to improve insulin sensitivity in obese pregnant women on health outcomes.

Funded Activity Details

Start Date: 01-01-2013

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $1,710,437.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Obstetrics and Gynaecology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

adiposity | infant health | maternal health | obesity | randomised trial